FOXO4-DRI enhances tissue rejuvenation By clearing out senescent cells, FOXO4-DRI can cause a significant increase in the regeneration of tissues and may restore their functionality, making it a promising agent for reversing cellular aging effects (4)

Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation
The most commonly used medication in this treatment is alprostadil, a synthetic version of prostaglandin E1 (PGE1)
It's awesome for those with restricted diets and On-the-goers with poor eating habits
References Monnier M, Dudler L, Gchter R, Maier PF, Tobler HJ, Schoenenberger GA